Daniel A.C. Fisher

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms”.

A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1652

N/A

0DataRank · unranked

32 citations

Ethan Krug, Christine R. Zhang, Wentao Han, Nancy Issa, Won Kyun Koh +12 more

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.27.449656

N/A

0DataRank · unranked

14 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Anthony Z. Wang +8 more

The Transmembrane Protein Semaphorin 6A Repels Embryonic Sympathetic Axons

UNC Libraries(2021)10.17615/p2zj-nz44

N/A

0DataRank · unranked

2 citations

Xiao Mei Xu, Fletcher A. White, Daniel A.C. Fisher, Lijuan Zhou, William D. Snidpper +2 more

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

Nature Cancer(2022)10.1038/s43018-022-00486-8

N/A

0DataRank · unranked

40 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Laure Poittevin De La Frégonnière +10 more

Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib

British Journal of Haematology(2022)10.1111/bjh.18044

N/A

0DataRank · unranked

21 citations

Tim Kong, Jared S. Fowles, Chun‐Ling Jung, Maggie J. Allen, Daniel A.C. Fisher +5 more

Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes

Experimental Hematology(2022)10.1016/j.exphem.2022.03.011

N/A

0DataRank · unranked

12 citations

Darlene Monlish, Zev J. Greenberg, Daniel A.C. Fisher, Matthew J. Walter, Stephen T. Oh +2 more

Multiomic Profiling Reveals Metabolic Alterations Mediating Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.08.519689

N/A

0DataRank · unranked

4 citations

Angelo B. A. Laranjeira, Tim Kong, Alice Liu, Katrina Ashworth, Nina Lasky +10 more

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry

Nature Communications(2023)10.1038/s41467-023-37123-6

N/A

0DataRank · unranked

61 citations

Karolyn A. Oetjen, Diane E. Bender, Marianna B. Ruzinova, Daniel A.C. Fisher, Kevin G. Shim +6 more

Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms

Journal of Clinical Investigation(2023)10.1172/jci172256

N/A

0DataRank · unranked

43 citations

Angelo B. A. Laranjeira, Tim Kong, Shuyang Lin, Katrina Ashworth, Alice Liu +13 more

Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms

American Journal of Hematology(2023)10.1002/ajh.26935

N/A

0DataRank · unranked

15 citations

LaYow Yu, Angelo B. A. Laranjeira, Daniel A.C. Fisher, Fan He, Maggie J. Cox +2 more

Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice

Experimental Hematology(2023)10.1016/j.exphem.2023.08.005

N/A

0DataRank · unranked

2 citations

Angelo B. A. Laranjeira, Tim Kong, Steven C. Snyder, Kevin G. Shim, Mary C. Fulbright +2 more

Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms

Experimental Hematology(2024)10.1016/j.exphem.2024.104178

N/A

0DataRank · unranked

2 citations

Angelo B. A. Laranjeira, Tim Kong, Mary C. Fulbright, Daniel A.C. Fisher, Christopher M. Sturgeon +3 more

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia

Nature Communications(2025)10.1038/s41467-024-55643-7

N/A

0DataRank · unranked

17 citations

Angelo B. A. Laranjeira, Christopher T. Letson, LaYow Yu, Shuyang Lin, Jared S. Fowles +20 more

A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies

Cell Communication and Signaling(2025)10.1186/s12964-025-02568-3

N/A

0DataRank · unranked

1 citations

Shuyang Lin, Bei Gao, Varun Ramesh, Alexander B. Kim, Tim Kong +10 more